Judge Invalidates Prometheus' Patent For Irritable Bowel Drug
Roxane Laboratories Inc. scored a victory Wednesday when a New Jersey federal judge invalidated Prometheus Laboratories Inc.'s patent on a treatment for irritable bowel syndrome, ending Prometheus' case accusing Roxane of...To view the full article, register now.
Already a subscriber? Click here to view full article